Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...
Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...
Hosted on MSN1mon
Scientists identify feature of aggressive non-small cell lung cancerMore information: Ling Cai et al, High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non–Small Cell Lung Cancer in Patients, Cancer Discovery (2025). DOI: 10.1158/2159-8290.CD ...
Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.
Practice this cycle for 5-10 minutes, ideally 2-3 times daily for optimal lung cleansing benefits. Position significantly impacts effectiveness, with certain postures enhancing lung expansion ...
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback